logo-loader
viewTruTrace Technologies Inc

Full interview: TruTrace Technologies prepares to start Phase 2 testing of verification pilot program

TruTrace Technologies (CSE: TTT) CEO Robert Galarza joined Steve Darling from Proactive in Toronto to shares new the company, along with with their Partners at Shoppers Drug Mart, is about to begin Phase two testing of the StrainSecure platform.

Galarza talked about another company that will be a part of that. Galarza also told Proactive about their strategic alliance with Deloitte and how key that is for this growing company. 

Quick facts: TruTrace Technologies Inc

Price: 0.115 CAD

CSE:TTT
Market: CSE
Market Cap: $9.22 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of TruTrace Technologies Inc named herein, including the promotion by the Company of TruTrace Technologies Inc in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: TruTrace Technologies ramps up cannabis verification for...

TruTrace Technologies Inc (CSE:TTT) (OTCMKTS:TTTSF) CEO Robert Galarza tells Proactive the technology company will be teaming up with telemedicine platform AdvancedCare, to expand throughout the medical cannabis space. Galarza says TrueTrace's StrainSecure technology, an integrated blockchain...

3 weeks, 6 days ago

2 min read